Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,915
Closed -$998K 195
2023
Q2
$998K Sell
10,915
-4,442
-29% -$364K 0.21% 154
2023
Q1
$1.13M Buy
15,357
+5,684
+59% +$492K 0.25% 141
2022
Q4
$811K Sell
9,673
-325
-3% -$29.3K 0.18% 167
2022
Q3
$967K Buy
9,998
+1,487
+17% +$177K 0.22% 146
2022
Q2
$895K Buy
8,511
+1,578
+23% +$202K 0.19% 153
2022
Q1
$1.2M Buy
+6,933
New +$1.04M 0.18% 157

Other funds holding AMED

EFG Asset Management's AMED Position: Q3 2023 in Review

EFG Asset Management sold out of Amedisys (AMED) in Q3 2023, closing a stake of 10,915 shares — an estimated $998K sold.

EFG Asset Management first reported a position in AMED in Q1 2022 and held it in 6 quarters. The position peaked at $1.2M in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • EFG Asset Management reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • EFG Asset Management sold 10,915 Amedisys shares in Q3 2023, an estimated $998K.
  • EFG Asset Management first reported a position in Amedisys in Q1 2022 and held it in 6 quarters.
  • EFG Asset Management's Amedisys position peaked at $1.2M in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on EFG Asset Management's 13F filing for Q3 2023, filed 2 Nov 2023.